Scroll for more
home Oct 3, 2017

Using Artificial Intelligence to revolutionise drug discovery and development

Jackie Hunter, CEO BenevolentBio shares her thoughts on how Artificial Intelligence is accelerating drug discovery

 

 


Interested in the topic? Read more about BenevolentAI's partnership with The Sheffield Institute for Translational Neuroscience (SITraN) in the search for a new cure for ALS (Amyotrophic Lateral Sclerosis)